Mobile navigation
Tests
Tests for Providers
Clinical Tests
Discover
Connect With Us
Tests for Patients
Cancer Tests
Learn
Need Help?
Resources
Resources for Providers
Resource Centers
Explore
Resources for Patients
Innovation
Technology
Research Use Only
Company
About Us
News & Events
Connect
Investors
Welcome
Financials
Governance
Investor Resources
Search
The Decipher GRID research-use-only data resource is shared with the scientific community to accelerate discoveries in prostate and bladder cancer.
The Decipher GRID (Genomic Resource for Intelligent Discovery) proprietary research-use-only database is designed to help advance understanding of urologic cancers at the molecular level.
The Decipher GRID data resource enables researchers and clinicians to uncover new insights into prostate and bladder cancer biology by providing access to:
Important
GRID data is for research use only and is not intended to guide patient management.
An optional research-use-only report that provides a subset of the locked signatures available when ordering a Decipher test
A data set of the signatures database for patients tested at your practice/institution
A custom collaboration across our data set around mutually defined research goals designed to advance the science
Research Report
Watch this video in which Dr. Ashley Ross, a Urologic Oncologist and Associate Professor of Urology at Northwestern Medicine, provides a page-by-page overview of the Decipher Prostate GRID Research Report.
Decipher GRID data access may require research collaboration agreements. Our medical and scientific teams work with qualified researchers to:
Research outcomes published in peer-reviewed journals contribute to scientific understanding but do not constitute clinical recommendations.
No. Decipher GRID is not for patient management or clinical decision-making. It is for research use only (RUO) and must be selected separately on the Decipher test requisition form (TRF) or ordering portal by checking the appropriate box.
No. Decipher GRID is delivered as a separate research-use-only report from the clinical Decipher test reports and must be selected separately on the Test Requisition Form (TRF) or ordering portal by checking the appropriate box.
Once the request is received and approved, data delivery typically takes up to three weeks.
Veracyte is building a repository of more than 200,000 digitized pathology slides to support cancer research.
Genomic information to help guide prostate cancer treatment decisions for clinicians and patients.
Explore how Decipher Bladder provides actionable insights by revealing underlying tumor biology.
A novel diagnostics platform helping unlock deeper cancer insights.
Veracyte publications and references showcasing discoveries and advancements.
This webpage contains forward-looking statements. These forward-looking statements involve risks and uncertainties. For more information, click here.